457 related articles for article (PubMed ID: 19657747)
1. Manganese and its role in Parkinson's disease: from transport to neuropathology.
Aschner M; Erikson KM; Herrero Hernández E; Tjalkens R
Neuromolecular Med; 2009; 11(4):252-66. PubMed ID: 19657747
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of manganese-associated neurotoxicity.
Racette BA; Aschner M; Guilarte TR; Dydak U; Criswell SR; Zheng W
Neurotoxicology; 2012 Aug; 33(4):881-6. PubMed ID: 22202748
[TBL] [Abstract][Full Text] [Related]
3. Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.
Roth JA
Neuromolecular Med; 2009; 11(4):281-96. PubMed ID: 19757210
[TBL] [Abstract][Full Text] [Related]
4. From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.
Lucchini RG; Martin CJ; Doney BC
Neuromolecular Med; 2009; 11(4):311-21. PubMed ID: 20012385
[TBL] [Abstract][Full Text] [Related]
5. Manganese homeostasis in the nervous system.
Chen P; Chakraborty S; Mukhopadhyay S; Lee E; Paoliello MM; Bowman AB; Aschner M
J Neurochem; 2015 Aug; 134(4):601-10. PubMed ID: 25982296
[TBL] [Abstract][Full Text] [Related]
6. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
[TBL] [Abstract][Full Text] [Related]
7. Pivotal roles of p53 transcription-dependent and -independent pathways in manganese-induced mitochondrial dysfunction and neuronal apoptosis.
Wan C; Ma X; Shi S; Zhao J; Nie X; Han J; Xiao J; Wang X; Jiang S; Jiang J
Toxicol Appl Pharmacol; 2014 Dec; 281(3):294-302. PubMed ID: 25448048
[TBL] [Abstract][Full Text] [Related]
8. Manganese and Parkinson's disease: a critical review and new findings.
Guilarte TR
Environ Health Perspect; 2010 Aug; 118(8):1071-80. PubMed ID: 20403794
[TBL] [Abstract][Full Text] [Related]
9. Manganese accumulation in the CNS and associated pathologies.
Rivera-Mancía S; Ríos C; Montes S
Biometals; 2011 Oct; 24(5):811-25. PubMed ID: 21533671
[TBL] [Abstract][Full Text] [Related]
10. Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.
Kwakye GF; Paoliello MM; Mukhopadhyay S; Bowman AB; Aschner M
Int J Environ Res Public Health; 2015 Jul; 12(7):7519-40. PubMed ID: 26154659
[TBL] [Abstract][Full Text] [Related]
11. Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity.
Karki P; Smith K; Johnson J; Aschner M; Lee E
Neurochem Int; 2015 Sep; 88():53-9. PubMed ID: 25128239
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.
Milatovic D; Zaja-Milatovic S; Gupta RC; Yu Y; Aschner M
Toxicol Appl Pharmacol; 2009 Oct; 240(2):219-25. PubMed ID: 19607852
[TBL] [Abstract][Full Text] [Related]
13. "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".
Peres TV; Schettinger MR; Chen P; Carvalho F; Avila DS; Bowman AB; Aschner M
BMC Pharmacol Toxicol; 2016 Nov; 17(1):57. PubMed ID: 27814772
[TBL] [Abstract][Full Text] [Related]
14. Molecular Targets of Manganese-Induced Neurotoxicity: A Five-Year Update.
Tinkov AA; Paoliello MMB; Mazilina AN; Skalny AV; Martins AC; Voskresenskaya ON; Aaseth J; Santamaria A; Notova SV; Tsatsakis A; Lee E; Bowman AB; Aschner M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925013
[TBL] [Abstract][Full Text] [Related]
15. The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease.
Settivari R; Levora J; Nass R
J Biol Chem; 2009 Dec; 284(51):35758-68. PubMed ID: 19801673
[TBL] [Abstract][Full Text] [Related]
16. Manganese and the brain.
Tuschl K; Mills PB; Clayton PT
Int Rev Neurobiol; 2013; 110():277-312. PubMed ID: 24209443
[TBL] [Abstract][Full Text] [Related]
17. Considerations on manganese (Mn) treatments for in vitro studies.
Bowman AB; Aschner M
Neurotoxicology; 2014 Mar; 41():141-2. PubMed ID: 24509086
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice.
El Fari R; Abbaoui A; Bourziq A; Zroudi M; Draoui A; El Khiat A; Belkouch M; Elgot A; Gamrani H
J Chem Neuroanat; 2019 Dec; 102():101686. PubMed ID: 31562917
[TBL] [Abstract][Full Text] [Related]
19. Manganese Control of Glutamate Transporters' Gene Expression.
Lee E; Karki P; Johnson J; Hong P; Aschner M
Adv Neurobiol; 2017; 16():1-12. PubMed ID: 28828603
[TBL] [Abstract][Full Text] [Related]
20. Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats.
Zheng W; Jiang YM; Zhang Y; Jiang W; Wang X; Cowan DM
Neurotoxicology; 2009 Mar; 30(2):240-8. PubMed ID: 19150464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
